Login to Your Account



WHO seeking to bring Merck Ebola vaccine to latest outbreak area

By Nuala Moran
Staff Writer

Friday, May 19, 2017

LONDON – The World Health Organization (WHO) is laying the groundwork for Merck & Co. Inc.'s unlicensed VSV-ZEBOV Ebola vaccine to be used to combat the new outbreak of the virus that started last month in the Democratic Republic of Congo (DRC).

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription